![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Acta Biomed |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Enfortumab Vedotin in metastatic bladder cancer: a case report of durable
clinical efficacy in a pretreated patient.
Acta Biomed. 2023;94.
PubMed
Abstract available
Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized
Muscle-Invasive Bladder Cancer.
Adv Radiat Oncol. 2022;8:101157.
PubMed
Abstract available
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity
Score-Matched Analysis.
Ann Surg Oncol. 2023 Mar 10. doi: 10.1245/s10434-023-13227.
PubMed
Abstract available
Letter to the editor regarding the article 'Do we need repeat transurethral
resection after en-bloc resection for pathological T1 bladder cancer?
BJU Int. 2023 Mar 10. doi: 10.1111/bju.16005.
PubMed
A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer
prognosis by a machine learning based methodology.
BMC Bioinformatics. 2023;23.
PubMed
Abstract available
Which data subset should be augmented for deep learning? a simulation study using
urothelial cell carcinoma histopathology images.
BMC Bioinformatics. 2023;24:75.
PubMed
Abstract available
Transurethral en bloc resection of a bladder perivascular epithelioid cell tumor
(PEComa): a case report.
BMC Urol. 2023;23:28.
PubMed
Abstract available
EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder
canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre
randomised controlled trial.
BMJ Open. 2023;13:e071304.
PubMed
Abstract available
Systematic radiomics analysis based on multiparameter MRI to preoperatively
predict the expression of Ki67 and histological grade in patients with bladder
cancer.
Br J Radiol. 2023 Mar 8:20221086. doi: 10.1259/bjr.20221086.
PubMed
Abstract available
Phenotype of Urine Sediment Cells in Patients with Bladder Cancer.
Bull Exp Biol Med. 2023 Mar 9. doi: 10.1007/s10517-023-05732.
PubMed
Abstract available
Disparities in cause-specific mortality by race and sex among bladder cancer
patients from the SEER database.
Cancer Causes Control. 2023 Mar 8. doi: 10.1007/s10552-023-01679.
PubMed
Abstract available
Cutoff values of PD-L1 expression in urinary cytology samples for predicting
response to immune checkpoint inhibitor therapy in upper urinary tract urothelial
carcinoma.
Cancer Cytopathol. 2023;131:179-187.
PubMed
Abstract available
DNA methylation analysis in urinary samples: A useful method to predict the risk
of neoplastic recurrence in patients with urothelial carcinoma of the bladder in
the high-risk group.
Cancer Cytopathol. 2023;131:158-164.
PubMed
Abstract available
Comparison between renal pelvic and ureteral tumors in muscle-invasive upper
tract urothelial carcinoma.
Cancer Sci. 2023;114:984-994.
PubMed
Abstract available
Probiotics enhances anti-tumor immune response induced by gemcitabine plus
cisplatin chemotherapy for urothelial cancer.
Cancer Sci. 2023;114:1118-1130.
PubMed
Abstract available
Adenoviral gene therapy for bladder cancer.
Cell. 2023;186:893.
PubMed
Abstract available
PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer
progression.
Cell Biosci. 2023;13:45.
PubMed
Abstract available
In vivo detection demonstrates circulating tumor cell reduction instead of
baseline number has prognostic value in bladder cancer patients receiving
neoadjuvant chemotherapy.
Cell Oncol (Dordr). 2023 Mar 6. doi: 10.1007/s13402-023-00785.
PubMed
Abstract available
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After
Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label,
Single-Arm, Phase 2 ARCADIA Trial.
Clin Genitourin Cancer. 2021;19:457-465.
PubMed
Abstract available
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial
Carcinoma Treated With First-line PD1/L1 Inhibitors.
Clin Genitourin Cancer. 2021;19:425-433.
PubMed
Abstract available
The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
Clin Genitourin Cancer. 2021;19:373-380.
PubMed
Abstract available
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease
Control in Patients With Metastatic Urothelial Carcinoma treated With
Immunotherapy.
Clin Genitourin Cancer. 2021;19:396-404.
PubMed
Abstract available
Comput Methods Programs Biomed
EDIT Software: A tool for the semi-automatic 3D reconstruction of bladder cancer
and urinary bladder of animal models.
Comput Methods Programs Biomed. 2023;232:107448.
PubMed
Abstract available
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and
Future Directions.
Curr Oncol Rep. 2023 Mar 10. doi: 10.1007/s11912-023-01390.
PubMed
Abstract available
PET in bladder cancer imaging.
Curr Opin Urol. 2023 Mar 7. doi: 10.1097/MOU.0000000000001090.
PubMed
Abstract available
Where To Draw the Line: Stratifying Risk for High-grade Ta Bladder Cancer.
Eur Urol Oncol. 2023 Mar 3:S2588-9311(23)00035-4. doi: 10.1016/j.euo.2023.
PubMed
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic
Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
Eur Urol Oncol. 2023 Mar 1:S2588-9311(23)00036-6. doi: 10.1016/j.euo.2023.
PubMed
Abstract available
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic
Opportunities.
Eur Urol Oncol. 2023 Mar 6:S2588-9311(23)00043-3. doi: 10.1016/j.euo.2023.
PubMed
Abstract available
Patient Preferences for Treatment of Bacillus Calmette-Guerin-unresponsive
Non-muscle-invasive Bladder Cancer: A Cross-country Choice Experiment.
Eur Urol Open Sci. 2023;49:92-99.
PubMed
Abstract available
Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis,
tumor microenvironment invasion, and drug sensitivity.
Front Oncol. 2023;13:1116305.
PubMed
Abstract available
Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is
associated with prognosis and immunotherapy response in bladder cancer.
Heliyon. 2023;9:e13707.
PubMed
Abstract available
Prediction of immune infiltration and prognosis for patients with urothelial
bladder cancer based on the DNA damage repair-related genes signature.
Heliyon. 2023;9:e13661.
PubMed
Abstract available
Drug-induced interstitial pneumonia after intravesical Bacillus Calmette-Guerin
administration for bladder cancer with scleroderma.
IJU Case Rep. 2023;6:133-136.
PubMed
Abstract available
Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer
With Rectal Metastases.
In Vivo. 2023;37:912-915.
PubMed
Abstract available
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in
combination with chemotherapy.
Int J Cancer. 2023 Mar 9. doi: 10.1002/ijc.34500.
PubMed
Abstract available
Comprehensive Analysis of the Expression, Prognosis, and Biological Significance
of PLOD Family in Bladder Cancer.
Int J Gen Med. 2023;16:707-722.
PubMed
Abstract available
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on
Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular
Invasive Bladder Urothelial Carcinoma.
Int J Mol Sci. 2021;22:9856.
PubMed
Abstract available
Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic
Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic
Signaling and the Tumor Immune Microenvironment.
Int J Mol Sci. 2021;22:9526.
PubMed
Abstract available
Chemotherapy with gemcitabine and cisplatin downregulates tumor expression level
of nectin-4 in a syngeneic model of murine MBT2 urothelial cancer cell line and
C3H mice.
Int J Urol. 2023;30:328-330.
PubMed
Editorial Comment on Transurethral lidocaine (100 mg) bladder irrigation
(TULI100) reduces the incidence of catheter-related bladder discomfort in TURBT:
A randomized, double-blind, controlled trial.
Int J Urol. 2023;30:270-271.
PubMed
Trends of radical cystectomy and comparisons of surgical outcomes among surgical
approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide
database study.
Int J Urol. 2023;30:258-263.
PubMed
Abstract available
Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the
incidence of catheter related bladder discomfort in transurethral resection of
bladder tumors: A randomized, double blind, controlled trial.
Int J Urol. 2023;30:264-270.
PubMed
Abstract available
Letter to the editor re: "assessing bladder cancer prognosis through circulating
tumor cell analysis and Ki-67 measurement".
Int Urol Nephrol. 2023 Mar 3. doi: 10.1007/s11255-023-03538.
PubMed
Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle
invasive bladder cancer.
Investig Clin Urol. 2023;64:103-106.
PubMed
Comparison of clinical outcomes in patients with localized or locally advanced
urothelial carcinoma treated with neoadjuvant chemotherapy involving
gemcitabine-cisplatin and high dose-intensity MVAC.
J Cancer Res Clin Oncol. 2021;147:3421-3429.
PubMed
Abstract available
Anticancer properties of cannabidiol and Delta(9)-tetrahydrocannabinol and
synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.
J Cannabis Res. 2023;5:7.
PubMed
Abstract available
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant
Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
J Clin Oncol. 2023;41:1618-1625.
PubMed
Abstract available
Evaluating the cost-utility of intravesical bacillus calmette-guerin versus
radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer
in the UK.
J Med Econ. 2023 Mar 10:1-19. doi: 10.1080/13696998.2023.2189860.
PubMed
Abstract available
Progression-associated molecular changes in basal/squamous and sarcomatoid
bladder carcinogenesis.
J Pathol. 2023;259:455-467.
PubMed
Abstract available
Coexistent urothelial papilloma and ureteric calculus in an 8-year-old child: A
rare co-occurrence.
J Postgrad Med. 2021;67:182-183.
PubMed
Blood-based protein biomarkers in bladder urothelial tumors.
J Proteomics. 2021;247:104329.
PubMed
Abstract available
Biochemical network analysis of protein-protein interactions to follow-up T1
bladder cancer patients.
J Proteomics. 2023 Mar 2:104865. doi: 10.1016/j.jprot.2023.104865.
PubMed
Abstract available
Contrast-enhanced Ultrasound Combined With Elastography for the Evaluation of
Muscle-invasive Bladder Cancer in Rats.
J Ultrasound Med. 2023 Mar 10. doi: 10.1002/jum.16216.
PubMed
Abstract available
Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately
Before Transurethral Resection of Bladder Tumor in Patients With
Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective,
Randomized Phase II Study.
J Urol. 2023 Mar 9:101097JU0000000000003407. doi: 10.1097/JU.0000000000003407.
PubMed
Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-beta, and CDK4 in
canine urothelial carcinoma.
J Vet Diagn Invest. 2023;35:109-115.
PubMed
Abstract available
Prevalence and risk estimation of cancer-predisposing genes for upper urinary
tract urothelial carcinoma in Japanese.
Jpn J Clin Oncol. 2022;52:1441-1445.
PubMed
Abstract available
Switch-maintenance avelumab immunotherapy following first-line chemotherapy for
patients with advanced, unresectable or metastatic urothelial carcinoma: the
first Japanese real-world evidence from a multicenter study.
Jpn J Clin Oncol. 2023;53:253-262.
PubMed
Abstract available
Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor
Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.
Lab Invest. 2023;103:100040.
PubMed
Abstract available
Artificial intelligence-based model for lymph node metastases detection on whole
slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
Lancet Oncol. 2023 Mar 6:S1470-2045(23)00061.
PubMed
Abstract available
Pulmonary thrombotic microangiopathy caused by neoplastic urothelial carcinoma
cells.
Med Clin (Barc). 2023;160:226-227.
PubMed
In brief: Adstiladrin - a gene therapy for bladder cancer.
Med Lett Drugs Ther. 2023;65:e40-e41.
PubMed
In vivo detection of circulating tumor cells predicts high-risk features in
patients with bladder cancer.
Med Oncol. 2023;40:113.
PubMed
Abstract available
[Frailty and surgical tolerability in elderly patients undergoing robot-assisted
radical cystectomy (RARC)].
Nihon Ronen Igakkai Zasshi. 2023;60:38-42.
PubMed
Abstract available
Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor
biopsies.
Nucleus. 2023;14:2186686.
PubMed
Abstract available
Regulation of CD8(+) T cells infiltration and immunotherapy by circMGA/HNRNPL
complex in bladder cancer.
Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02637.
PubMed
Abstract available
Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder
Cancer Screening and Diagnosis: A Systematic Review.
Pharmacoeconomics. 2023 Mar 8. doi: 10.1007/s40273-023-01256.
PubMed
Abstract available
CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in
the diagnosis of low-grade urothelial carcinoma.
PLoS One. 2023;18:e0281873.
PubMed
Abstract available
[Pathological pelvic lymph node involvement in muscle-invasive bladder cancer
patients treated with radical cystectomy: A narrative review].
Prog Urol. 2023;33:145-154.
PubMed
Abstract available
Mining The Cancer Genome Atlas gene expression data for lineage markers in
distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Sci Rep. 2021;11:6765.
PubMed
Abstract available
Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a
nationwide cohort study.
Sci Rep. 2023;13:3682.
PubMed
Abstract available
Early experience with UGN-101 for the treatment of upper tract urothelial cancer
- A multicenter evaluation of practice patterns and outcomes.
Urol Oncol. 2023;41:147.
PubMed
Abstract available
Conditional survival after radical cystectomy for non-metastatic muscle-invasive
squamous cell carcinoma of the urinary bladder: A population-based analysis.
Urol Oncol. 2023;41:147.
PubMed
Abstract available
Actionable genomic landscapes from a real-world cohort of urothelial carcinoma
patients.
Urol Oncol. 2023;41:148.
PubMed
Abstract available
Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder
cancer.
Urol Oncol. 2023 Mar 1:S1078-1439(23)00009-1. doi: 10.1016/j.urolonc.2023.
PubMed
Abstract available
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With
Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
Urol Oncol. 2023 Mar 5:S1078-1439(23)00015-7. doi: 10.1016/j.urolonc.2023.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by